Search for: "ASTRAZENECA LP" Results 101 - 120 of 155
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Astrazeneca Pharmaceutical LP held a leave of absence or a leave extension can constitute a reasonable accommodation under the ADA “in some circumstances”, although in that case ultimately concluded the plaintiff could not show her request for twelve additional months of leave was facially reasonable. [read post]
29 Jun 2010, 6:01 pm by Duncan
(Docket Report) US: Update on reverse settlement agreements – Amici curiae brief filed with US Court of Appeals: In re Ciprofloxacin Hydrochloride Antitrust Litigation (IP Whiteboard) (PatLit) US: An uneven debate on ‘takings’ in pharmaceutical patent law (Patent Docs) Products Aldara (Imiquimod) – US: Graceway’s injunction and Nycomed’s dismissal denied in Aldara suit (Patent Docs) Argatroban – US: Patent for Argatroban found valid, injunction… [read post]
16 Apr 2012, 1:29 am by FDABlog HPM
District Court are Motions for Summary Judgment filed by FDA and AstraZeneca Pharmaceuticals LP (here and here) concerning FDA’s approval of ANDAs for generic versions of SEROQUEL (quetiapine fumarate) Tablets and the Agency’s decision, discussed in a March 27, 2012 Letter Decision, concerning the scope and applicability of 3-year marketing exclusivity in that case. [read post]
16 Jan 2009, 5:00 am
(IP finance) US: Medarex, Eurand and Alexion file actions against Director Dudas seeking revised patent term adjustment determinations (Patent Docs) US: Kubin panel questions motivation behind reversal in new Written Description Training Materials (Patent Docs) US: The obviousness of DNA - Federal Circuit heard oral argument for In re Kubin last week (Patent Docs)   Products Antara (Fenofibrate) – US: Oscient and Ethypharm file patent infringement suit against Lupin over Antara… [read post]
30 Jun 2010, 5:52 am
(Docket Report) US: Update on reverse settlement agreements – Amici curiae brief filed with US Court of Appeals: In re Ciprofloxacin Hydrochloride Antitrust Litigation (IP Whiteboard) (PatLit) US: An uneven debate on ‘takings’ in pharmaceutical patent law (Patent Docs)   Products Aldara (Imiquimod) – US: Graceway’s injunction and Nycomed’s dismissal denied in Aldara suit (Patent Docs) Argatroban – US: Patent for Argatroban found valid, injunction issued… [read post]
Astrazeneca Pharmaceutical LP held a leave of absence or a leave extension can constitute a reasonable accommodation under the ADA “in some circumstances”, although in that case ultimately concluded the plaintiff could not show her request for twelve additional months of leave was facially reasonable. [read post]
23 Jul 2009, 3:15 am
Astrazeneca Pharmaceuticals LP), because of Bexis' firm's involvement in the litigation (although not this aspect). [read post]
8 Apr 2015, 3:41 pm by Sean Wajert
AstraZeneca Pharm., LP, 634 F.3d 1352, 1362 (11th Cir. 2011) (“Several considerations shape the physician’s medical judgment, including both individual patient concerns and drug-specific information regarding the propriety of a drug’s use for treatment of a patient’s given condition . . . [read post]
26 Jan 2011, 1:31 am by Ben Vernia
In April of last year, we obtained a $520 million settlement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to resolve allegations that marketing of the anti-psychotic drug Seroquel for uses not approved as safe and effective by the FDA caused false claims to be submitted to federal health care programs. [read post]
25 Oct 2013, 3:56 am by Lorene Park
In the court’s view, this circumstantial evidence of a “pattern of antagonism” raised an inference of retaliation and was enough to support her Title VII claim (Brangman v AstraZeneca, LP). [read post]
18 Mar 2024, 9:46 am by Kalvis Golde
AstraZeneca Pharmaceuticals, LP 23-665Issue: Whether, where an unemployment applicant’s religious beliefs are independently sufficient to cause her refusal to follow an employer policy, a state can deny her unemployment benefits by holding that philosophical and personal beliefs outweigh her religious beliefs. [read post]
16 May 2012, 12:22 pm by Bexis
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352, 1360-66 (11th Cir. 2011) (plaintiff had not pleaded recoverable economic injury); Polk v. [read post]